Zhaoke Ophthalmology Limited
Zhaoke Ophthalmology Limited, an ophthalmic pharmaceutical company, engages in the research, development, manufacture, and commercialization of therapies that address unmet medical needs in the People's Republic of China, South Korea, Hong Kong, and internationally. It develops various drugs that cover ophthalmic indications, including dry eye disease, myopia, presbyopia, wet age-related macular … Read more
Zhaoke Ophthalmology Limited (9FX) - Total Assets
Latest total assets as of June 2025: €2.07 Billion EUR
Based on the latest financial reports, Zhaoke Ophthalmology Limited (9FX) holds total assets worth €2.07 Billion EUR as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Zhaoke Ophthalmology Limited - Total Assets Trend (2021–2024)
This chart illustrates how Zhaoke Ophthalmology Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Zhaoke Ophthalmology Limited - Asset Composition Analysis
Current Asset Composition (December 2024)
Zhaoke Ophthalmology Limited's total assets of €2.07 Billion consist of 72.0% current assets and 28.0% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 50.0% |
| Accounts Receivable | €1.38 Million | 0.1% |
| Inventory | €14.90 Million | 0.7% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €413.55 Million | 18.4% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2021–2024)
This chart illustrates how Zhaoke Ophthalmology Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Zhaoke Ophthalmology Limited's current assets represent 72.0% of total assets in 2024, a decrease from 84.8% in 2021.
- Cash Position: Cash and equivalents constituted 50.0% of total assets in 2024, down from 81.7% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 18.0% of total assets, an increase from 6.0% in 2021.
- Asset Diversification: The largest asset category is intangible assets at 18.4% of total assets.
Zhaoke Ophthalmology Limited Competitors by Total Assets
Key competitors of Zhaoke Ophthalmology Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Zhaoke Ophthalmology Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Zhaoke Ophthalmology Limited generates 0.03x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Zhaoke Ophthalmology Limited is currently not profitable relative to its asset base.
Zhaoke Ophthalmology Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.40 | 5.52 | 5.52 |
| Quick Ratio | 4.36 | 5.48 | 5.48 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €1.14 Billion | € 1.44 Billion | € 1.44 Billion |
Zhaoke Ophthalmology Limited - Advanced Valuation Insights
This section examines the relationship between Zhaoke Ophthalmology Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.86 |
| Latest Market Cap to Assets Ratio | 0.05 |
| Asset Growth Rate (YoY) | -7.3% |
| Total Assets | €2.24 Billion |
| Market Capitalization | $118.66 Million USD |
Valuation Analysis
Below Book Valuation: The market values Zhaoke Ophthalmology Limited's assets below their book value (0.05 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Zhaoke Ophthalmology Limited's assets decreased by 7.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Zhaoke Ophthalmology Limited (2021–2024)
The table below shows the annual total assets of Zhaoke Ophthalmology Limited from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €2.24 Billion | -7.31% |
| 2023-12-31 | €2.42 Billion | -5.85% |
| 2022-12-31 | €2.57 Billion | -1.34% |
| 2021-12-31 | €2.61 Billion | -- |